.secondary-pathway {
            stroke: #8b7575;
            stroke-width: 2;
            fill: none;
            stroke-dasharray: 5,5;
            opacity: 0.7;
            marker-end: url(#arrowhead);
        }<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Acetaminophen-ASD Mechanistic Pathways</title>
    <style>
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            margin: 0;
            padding: 20px;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            min-height: 100vh;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            background: white;
            border-radius: 15px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
            padding: 30px;
        }
        
        h1 {
            text-align: center;
            color: #2c3e50;
            margin-bottom: 10px;
            font-size: 28px;
        }
        
        .subtitle {
            text-align: center;
            color: #7f8c8d;
            margin-bottom: 30px;
            font-size: 14px;
        }
        
        svg {
            width: 100%;
            height: 750px;
            background: white;
        }
        
        .node {
            cursor: pointer;
            transition: all 0.3s ease;
        }
        
        .node:hover {
            filter: brightness(1.1);
        }
        
        .primary-node {
            fill: #e74c3c;
            stroke: #c0392b;
            stroke-width: 2;
            filter: drop-shadow(0px 2px 4px rgba(0,0,0,0.2));
        }
        
        .mechanism-node {
            fill: #3498db;
            stroke: #2980b9;
            stroke-width: 2;
        }
        
        .intermediate-node {
            fill: #f39c12;
            stroke: #e67e22;
            stroke-width: 2;
        }
        
        .convergence-node {
            fill: #9b59b6;
            stroke: #8e44ad;
            stroke-width: 2;
        }
        
        .outcome-node {
            fill: #e74c3c;
            stroke: #c0392b;
            stroke-width: 3;
        }
        
        .secondary-outcome-node {
            fill: #b89b9b;
            stroke: #8b7575;
            stroke-width: 2;
        }
        
        .node-text {
            fill: white;
            font-size: 12px;
            font-weight: 500;
            text-anchor: middle;
            pointer-events: none;
        }
        
        .pathway-arrow {
            stroke: #34495e;
            stroke-width: 2;
            fill: none;
            marker-end: url(#arrowhead);
            opacity: 0.7;
        }
        
        .critical-pathway {
            stroke: #e74c3c;
            stroke-width: 3;
            opacity: 0.8;
        }
        
        .secondary-pathway {
            stroke: #8b7575;
            stroke-width: 2;
            fill: none;
            stroke-dasharray: 3,3;
            opacity: 0.6;
        }
        
        .legend {
            display: flex;
            justify-content: center;
            gap: 30px;
            margin-top: 20px;
            padding: 15px;
            background: #f8f9fa;
            border-radius: 8px;
        }
        
        .legend-item {
            display: flex;
            align-items: center;
            gap: 8px;
            font-size: 13px;
            color: #555;
        }
        
        .legend-box {
            width: 20px;
            height: 20px;
            border-radius: 4px;
            border: 1px solid #999;
        }
        
        .info-box {
            position: absolute;
            background: rgba(0,0,0,0.85);
            color: white;
            padding: 12px;
            border-radius: 8px;
            font-size: 12px;
            max-width: 250px;
            display: none;
            z-index: 1000;
            line-height: 1.4;
        }
        
        .critical-period {
            fill: #fff5f5;
            stroke: #e74c3c;
            stroke-width: 1;
            stroke-dasharray: 5,5;
            opacity: 0.3;
        }
        
        .period-label {
            fill: #e74c3c;
            font-size: 11px;
            font-style: italic;
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Mechanistic Pathways: Prenatal Acetaminophen → ASD Risk</h1>
        <div class="subtitle">Multi-scale convergent mechanisms from exposure to neurodevelopmental outcomes</div>
        
        <svg id="pathway-diagram">
            <defs>
                <marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                    <polygon points="0 0, 10 3, 0 6" fill="#34495e"/>
                </marker>
                <marker id="critical-arrow" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                    <polygon points="0 0, 10 3, 0 6" fill="#e74c3c"/>
                </marker>
            </defs>
            
            <!-- Critical periods background -->
            <rect class="critical-period" x="50" y="125" width="250" height="425" rx="10"/>
            <text class="period-label" x="175" y="120">1st Trimester (Hormones)</text>
            
            <rect class="critical-period" x="350" y="125" width="250" height="425" rx="10"/>
            <text class="period-label" x="475" y="120">2nd Trimester (Migration)</text>
            
            <rect class="critical-period" x="650" y="125" width="250" height="425" rx="10"/>
            <text class="period-label" x="775" y="120">3rd Trimester (Myelination)</text>
            
            <!-- Placental Transfer -->
            <rect class="node intermediate-node" x="395" y="55" width="160" height="35" rx="15"/>
            <text class="node-text" x="475" y="77">Placental Transfer (95%)</text>
            
            <!-- Primary Mechanisms -->
            <rect class="node mechanism-node" x="80" y="200" width="140" height="40" rx="15"/>
            <text class="node-text" x="150" y="220">CYP2E1 Metabolism</text>
            <text class="node-text" x="150" y="232" style="font-size:10px">→ NAPQI Formation</text>
            
            <rect class="node mechanism-node" x="250" y="200" width="140" height="40" rx="15"/>
            <text class="node-text" x="320" y="220">Endocrine Disruption</text>
            <text class="node-text" x="320" y="232" style="font-size:10px">↓ Testosterone 40%</text>
            
            <rect class="node mechanism-node" x="420" y="200" width="140" height="40" rx="15"/>
            <text class="node-text" x="490" y="220">Folate Depletion</text>
            <text class="node-text" x="490" y="232" style="font-size:10px">SAM/SAH Imbalance</text>
            
            <rect class="node mechanism-node" x="590" y="200" width="140" height="40" rx="15"/>
            <text class="node-text" x="660" y="220">Prostaglandin Block</text>
            <text class="node-text" x="660" y="232" style="font-size:10px">↓ PGE2 Signaling</text>
            
            <rect class="node mechanism-node" x="760" y="200" width="140" height="40" rx="15"/>
            <text class="node-text" x="830" y="220">Direct Cell Toxicity</text>
            <text class="node-text" x="830" y="232" style="font-size:10px">OPC Vulnerability</text>
            
            <!-- Secondary Effects -->
            <rect class="node intermediate-node" x="80" y="290" width="140" height="35" rx="15"/>
            <text class="node-text" x="150" y="310">Oxidative Stress (ROS)</text>
            
            <rect class="node intermediate-node" x="250" y="290" width="140" height="35" rx="15"/>
            <text class="node-text" x="320" y="310">Brain Masculinization ↓</text>
            
            <rect class="node intermediate-node" x="420" y="290" width="140" height="35" rx="15"/>
            <text class="node-text" x="490" y="310">DNA Methylation Δ</text>
            
            <rect class="node intermediate-node" x="590" y="290" width="140" height="35" rx="15"/>
            <text class="node-text" x="660" y="310">Cerebellar Effects</text>
            
            <rect class="node intermediate-node" x="760" y="290" width="140" height="35" rx="15"/>
            <text class="node-text" x="830" y="310">↓ OPC (90% @ 20mM)</text>
            
            <!-- Cellular Consequences -->
            <rect class="node intermediate-node" x="165" y="370" width="140" height="35" rx="15"/>
            <text class="node-text" x="235" y="390">Mitochondrial Dysfunction</text>
            
            <rect class="node intermediate-node" x="335" y="370" width="140" height="35" rx="15"/>
            <text class="node-text" x="405" y="390">Synapse Formation ↓</text>
            
            <rect class="node intermediate-node" x="505" y="370" width="140" height="35" rx="15"/>
            <text class="node-text" x="575" y="390">Gene Expression Δ</text>
            
            <rect class="node intermediate-node" x="675" y="370" width="140" height="35" rx="15"/>
            <text class="node-text" x="745" y="390">Myelination Delay</text>
            
            <!-- Convergence -->
            <rect class="node convergence-node" x="290" y="450" width="180" height="40" rx="20"/>
            <text class="node-text" x="380" y="470">Altered White Matter</text>
            <text class="node-text" x="380" y="482" style="font-size:10px">Development</text>
            
            <rect class="node convergence-node" x="510" y="450" width="180" height="40" rx="20"/>
            <text class="node-text" x="600" y="470">Connectome Remodeling</text>
            <text class="node-text" x="600" y="482" style="font-size:10px">↓ Long-range connectivity</text>
            
            <!-- Final Outcomes -->
            <rect class="node outcome-node" x="375" y="570" width="200" height="45" rx="20"/>
            <text class="node-text" x="475" y="592">Increased ASD Risk</text>
            <text class="node-text" x="475" y="605" style="font-size:10px">OR: 1.2-1.3 (meta-analyses)</text>
            
            <rect class="node secondary-outcome-node" x="700" y="570" width="180" height="45" rx="20"/>
            <text class="node-text" x="790" y="592">Increased GID Risk</text>
            <text class="node-text" x="790" y="605" style="font-size:10px">Via masculinization disruption</text>
            
            <!-- Arrows -->
            <!-- From exposure to transfer -->
            <path class="pathway-arrow critical-pathway" d="M 475 45 L 475 55"/>
            
            <!-- From transfer to mechanisms -->
            <path class="pathway-arrow" d="M 400 90 L 220 200"/>
            <path class="pathway-arrow" d="M 430 90 L 320 200"/>
            <path class="pathway-arrow" d="M 475 90 L 490 200"/>
            <path class="pathway-arrow" d="M 520 90 L 660 200"/>
            <path class="pathway-arrow" d="M 550 90 L 760 200"/>
            
            <!-- From primary to secondary -->
            <path class="pathway-arrow critical-pathway" d="M 150 240 L 150 290"/>
            <path class="pathway-arrow critical-pathway" d="M 320 240 L 320 290"/>
            <path class="pathway-arrow" d="M 490 240 L 490 290"/>
            <path class="pathway-arrow" d="M 660 240 L 660 290"/>
            <path class="pathway-arrow critical-pathway" d="M 830 240 L 830 290"/>
            
            <!-- From secondary to cellular -->
            <path class="pathway-arrow" d="M 150 325 L 200 370"/>
            <path class="pathway-arrow" d="M 320 325 L 370 370"/>
            <path class="pathway-arrow" d="M 490 325 L 540 370"/>
            <path class="pathway-arrow" d="M 660 325 L 710 370"/>
            <path class="pathway-arrow" d="M 830 325 L 780 370"/>
            
            <!-- From cellular to convergence -->
            <path class="pathway-arrow" d="M 235 405 L 340 450"/>
            <path class="pathway-arrow" d="M 405 405 L 380 450"/>
            <path class="pathway-arrow" d="M 575 405 L 600 450"/>
            <path class="pathway-arrow critical-pathway" d="M 745 405 L 640 450"/>
            
            <!-- From convergence to outcomes -->
            <path class="pathway-arrow critical-pathway" d="M 380 490 L 430 570"/>
            <path class="pathway-arrow critical-pathway" d="M 600 490 L 520 570"/>
            
            <!-- From connectome and masculinization to GID -->
            <path class="pathway-arrow" d="M 650 470 L 700 570"/>
            <!-- Secondary path from Brain Masculinization to GID (routed below nodes to avoid overlap) -->
            <path class="secondary-pathway" d="M 390 307 L 410 307 L 410 510 L 770 510 L 770 570"/>
            
            <!-- Primary Exposure (placed last for highest z-index) -->
            <rect class="node primary-node" x="375" y="5" width="200" height="40" rx="20"/>
            <text class="node-text" x="475" y="30">Maternal APAP Exposure</text>
        </svg>
        
        <div class="legend">
            <div class="legend-item">
                <div class="legend-box" style="background: #e74c3c;"></div>
                <span>Primary Outcome (ASD)</span>
            </div>
            <div class="legend-item">
                <div class="legend-box" style="background: #b89b9b;"></div>
                <span>Secondary Outcome (GID)</span>
            </div>
            <div class="legend-item">
                <div class="legend-box" style="background: #3498db;"></div>
                <span>Primary Mechanisms</span>
            </div>
            <div class="legend-item">
                <div class="legend-box" style="background: #f39c12;"></div>
                <span>Intermediate Effects</span>
            </div>
            <div class="legend-item">
                <div class="legend-box" style="background: #9b59b6;"></div>
                <span>Convergent Pathways</span>
            </div>
            <div class="legend-item">
                <div style="width: 40px; height: 3px; background: #e74c3c;"></div>
                <span>Critical Pathways</span>
            </div>
            <div class="legend-item">
                <svg width="40" height="10">
                    <line x1="0" y1="5" x2="40" y2="5" stroke="#8b7575" stroke-width="2" stroke-dasharray="5,5"/>
                </svg>
                <span>Theoretical Links</span>
            </div>
        </div>
    </div>
    
    <div id="info-box" class="info-box"></div>
    
    <script>
        // Add interactive tooltips
        const nodes = document.querySelectorAll('.node');
        const infoBox = document.getElementById('info-box');
        
        const nodeInfo = {
            'Maternal APAP Exposure': 'Acetaminophen readily crosses placental barrier with ~95% efficiency, reaching fetal circulation within 30 minutes.',
            'CYP2E1 Metabolism': 'Fetal liver and brain express CYP2E1, converting APAP to toxic NAPQI metabolite that depletes glutathione.',
            'Endocrine Disruption': 'Ex vivo studies show 40-45% reduction in fetal testosterone. Also affects thyroid hormone and prostaglandin pathways.',
            'Folate Depletion': 'APAP metabolism consumes folate, disrupting SAM/SAH ratio critical for DNA methylation.',
            'Prostaglandin Block': 'COX inhibition reduces PGE2, affecting cerebellar development and oligodendrocyte maturation.',
            'Direct Cell Toxicity': 'In vitro: 90% OPC death at 20mM, 25% marker reduction at 1mM. Astrocyte reactivity observed.',
            'Oxidative Stress (ROS)': 'NAPQI generates reactive oxygen species, overwhelming fetal antioxidant capacity.',
            'Brain Masculinization ↓': 'Reduced testosterone during critical window (8-14 weeks) affects sexually dimorphic brain regions, potentially influencing gender-typical neural patterns.',
            'DNA Methylation Δ': 'Cord blood studies show differential methylation at neurodevelopmental genes.',
            'Myelination Delay': 'Reduced OPC population and BDNF leads to hypomyelination of neural pathways.',
            'Connectome Remodeling': 'MRI studies (Baker 2020) show reduced frontoparietal connectivity in exposed children. May interact with masculinization patterns.',
            'Increased ASD Risk': 'Meta-analyses show OR 1.2-1.3 for ASD/ADHD with prenatal exposure, higher with prolonged use.',
            'Increased GID Risk': 'Theoretical risk via disrupted brain masculinization and altered connectivity patterns during critical periods of gender-typical brain development.'
        };
        
        nodes.forEach(node => {
            node.addEventListener('mouseenter', (e) => {
                const rect = node.getBoundingClientRect();
                const text = node.querySelector('.node-text').textContent;
                
                if (nodeInfo[text]) {
                    infoBox.textContent = nodeInfo[text];
                    infoBox.style.display = 'block';
                    infoBox.style.left = rect.left + 'px';
                    infoBox.style.top = (rect.bottom + 5) + 'px';
                }
            });
            
            node.addEventListener('mouseleave', () => {
                infoBox.style.display = 'none';
            });
        });
    </script>
</body>
</html>